Literature DB >> 23278537

Invasive aspergillosis in children and adolescents.

Andreas H Groll1, Dominik Schrey, Athanasios Tragiannidis, Konrad Bochennek, Thomas Lehrnbecher.   

Abstract

Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised children. Disease control depends on prevention, early diagnosis, predictive microbiological information, prompt and appropriate treatment and restoration of host defenses. Relative to adults, invasive aspergillosis in children and adolescents is unique in its clinical presentation, epidemiology, and in particular, the utility of newer diagnostic tools and the pharmacokinetics of active antifungal agents. Here we review the presentation and epidemiology of invasive aspergillosis in children and adolescents and discuss the value of current diagnostic tools and strategies and options for treatment and prevention in this special population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23278537     DOI: 10.2174/13816128113199990311

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

Review 1.  Methods of Controlling Invasive Fungal Infections Using CD8+ T Cells.

Authors:  Pappanaicken R Kumaresan; Thiago Aparecido da Silva; Dimitrios P Kontoyiannis
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

2.  Nosocomial legionellosis and invasive aspergillosis in a child with T-lymphoblastic leukemia.

Authors:  Rhoikos Furtwängler; Uwe Schlotthauer; Barbara Gärtner; Norbert Graf; Arne Simon
Journal:  Int J Hyg Environ Health       Date:  2017-05-13       Impact factor: 5.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.